Adanate
PrivateLast Round
Series A
Nov 17, 2021
Total Funding Raised
$30M
Company Overview
Adanate is a biotechnology company that develops antibody therapeutics aimed at boosting innate and adaptive immunity to effectively manage cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adanate Comps
Public and private peers based on sector, stage, and business model.
Adanate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 17, 2021 |
Key People
Founding team and executive leadership
Adanate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village Biopartners | Series A |
| Avalon Ventures | Series A |
Adanate Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adanate's valuation, stock price, and market status.
